Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19689397rdf:typepubmed:Citationlld:pubmed
pubmed-article:19689397lifeskim:mentionsumls-concept:C0007610lld:lifeskim
pubmed-article:19689397lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:19689397lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:19689397lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:19689397lifeskim:mentionsumls-concept:C0301869lld:lifeskim
pubmed-article:19689397lifeskim:mentionsumls-concept:C0045330lld:lifeskim
pubmed-article:19689397pubmed:issue4lld:pubmed
pubmed-article:19689397pubmed:dateCreated2009-8-19lld:pubmed
pubmed-article:19689397pubmed:abstractTextTriiodobenzoic acid (TIBA) represents the core structure of most clinically used contrast agents for computed tomography and other X-ray procedures. To construct an intracellular radiopaque contrast agent, TIBA was coupled to various different positively and negatively charged fluorescein iothiocyanate (FITC)-labelled peptides. TIBA coupled to the SV40 T Antigen nuclear localization sequence (NLS) stained 80% of human glioma cells and caused cell death. This occurred with C- or N-terminal binding of TIBA and with the correct or mutant NLS. No cell death and only small numbers of stained cells (below 3 %) were observed after incubation with NLS conjugates lacking TIBA or after incubation with TIBA-conjugates containing a negatively charged polyglutamic acid stretch. TIBA-conjugates containing the Antennapedia-derived cell-penetrating peptide penetratin were only nuclearly taken up when TIBA and FITC were coupled to lysines outside the 16-amino acid peptide sequence. The study shows that intracellular TIBA may have potential as a chemotherapeutic agent rather than a contrast agent.lld:pubmed
pubmed-article:19689397pubmed:languageenglld:pubmed
pubmed-article:19689397pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19689397pubmed:citationSubsetIMlld:pubmed
pubmed-article:19689397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19689397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19689397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19689397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19689397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19689397pubmed:statusMEDLINElld:pubmed
pubmed-article:19689397pubmed:monthJullld:pubmed
pubmed-article:19689397pubmed:issn1875-6638lld:pubmed
pubmed-article:19689397pubmed:authorpubmed-author:VogelUlrichUlld:pubmed
pubmed-article:19689397pubmed:authorpubmed-author:EchnerHartmut...lld:pubmed
pubmed-article:19689397pubmed:authorpubmed-author:KalbacherHube...lld:pubmed
pubmed-article:19689397pubmed:authorpubmed-author:HecklStefanSlld:pubmed
pubmed-article:19689397pubmed:authorpubmed-author:BeckAlexander...lld:pubmed
pubmed-article:19689397pubmed:authorpubmed-author:GharabaghiAli...lld:pubmed
pubmed-article:19689397pubmed:authorpubmed-author:SturzuAlexand...lld:pubmed
pubmed-article:19689397pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19689397pubmed:volume5lld:pubmed
pubmed-article:19689397pubmed:ownerNLMlld:pubmed
pubmed-article:19689397pubmed:authorsCompleteYlld:pubmed
pubmed-article:19689397pubmed:pagination385-91lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:meshHeadingpubmed-meshheading:19689397...lld:pubmed
pubmed-article:19689397pubmed:year2009lld:pubmed
pubmed-article:19689397pubmed:articleTitleCell nucleus directed 2,3,5-triiodobenzoic acid conjugates.lld:pubmed
pubmed-article:19689397pubmed:affiliationDepartment of Neuroradiology; University of Tübingen; Hoppe-Seyler-Str.3; 72076 Tübingen, Germany.lld:pubmed
pubmed-article:19689397pubmed:publicationTypeJournal Articlelld:pubmed